TROY, NY – St. Peter's Health Partners has been
selected to partner with the American Cancer Society in the largest cancer
prevention study ever conducted in the United States.
Cancer Prevention Study-3, or CPS-3, is a long-term
epidemiology study planned for the next 20-30 years. It will involve more than
300,000 people of various racial and ethnic backgrounds recruited nationwide.
SPHP hopes to recruit more than 800 volunteers through
its four hospitals in the Capital Region, including St. Peter's Hospital and
Albany Memorial Hospital in Albany; Samaritan Hospital and St. Mary's Hospital
in Troy; and The Eddy network of services. Men and women between the ages of 30-65
years old who have never been diagnosed with cancer are eligible to enroll.
Basal or squamous cell skin cancer diagnoses will not disqualify a volunteer
“We all know someone a loved one or a friend
– whose life has been touched by cancer,” James K. Reed, MD, president and
chief executive officer of St. Peter's Health Partners, said. “This is a
historic study, and a once-in-a-lifetime opportunity to be a part of what is
potentially life-saving research.”
“More than 11 million people have survived
cancer, so as the largest health system in the Capital Region, we are proud to
be selected to partner in what will be the next wave of cancer prevention and
cancer solutions,” he added. “By enrolling to become a participant,
all of us are helping to protect our future generations – our children and
grandchildren – from ever developing this horrible disease.”
More than 300 scientific articles have already been
published from previous American Cancer Society studies. These studies have
demonstrated vital findings that significantly impact our health, including the
link between cigarette smoking and lung cancer; the role of being overweight or
obese on the risk of cancer occurrence and death; the link of physical activity
and lower risk of various cancers (including breast, colon and prostate
cancers); and the impact of hormones, diet, various medications and vitamins,
and a variety of other factors in relation to cancer risk.
Enrollment of participants for the CPS-3 study
launched on December 6, 2006 and will close on December 6, 2013. Such new
follow-up studies are needed as the current study population ages and
environmental and individual lifestyles change over time. Enrollees will be
asked to complete follow-up surveys at home every few years for the next 20-30
years to help researchers build on evidence from earlier studies, and better
understand the lifestyle, environmental and genetic factors that cause or
Enrollment sessions will be held at two SPHP
locations: Wednesday, Dec. 4 from 11:30 a.m. – 5:30 p.m. at St. Peter's Hospital
and Friday, Dec. 6 from 10:30 a.m. – 3:30 p.m. at Samaritan Hospital.
Appointment times can be scheduled online at www.cps3AlbanyTroy.org.
Participants will be asked to sign a consent form and
complete a brief survey, waist circumference will be recorded and a small blood
sample will also be drawn. All information will be kept confidential.
For more information, call St. Peter's Cancer Care
Line at (518) 525-1547.